top of page
Dr. Tao Jiang - Neurosurgeon - Beijing Tiantan Hospital Beijing

Professional Title & Qualifications:

  • Academician of the Chinese Academy of Engineering,

  • Chief Physician,

  • Professor,

  • Doctoral Supervisor

Specialization: 

Neurosurgery

Hospital & Department：

Beijing Tiantan Hospital – Department of Neurosurgery

(address: No. 119 South Fourth Ring West Road, Fengtai District, Beijing, 100070)

Dr. Tao Jiang (江涛) - Neurosurgery Specialist

Personal Biography

Dr. Tao Jiang, born in 1964 in Harbin, is a highly specialized neurosurgeon and an Academician of the Chinese Academy of Engineering. He obtained his Master's and Ph.D. degrees in neurosurgery from Harbin Medical University between 1991 and 1996. Following his doctoral studies, Dr. Jiang completed postdoctoral research at Beijing Tiantan Hospital under the mentorship of Dr. Wang Zhongcheng. To further his expertise in neuro-oncology, he subsequently served as a postdoctoral researcher at the MD Anderson Cancer Center at the University of Texas in the United States from 2002 to 2004.

​

Throughout his extensive clinical career, Dr. Jiang has focused deeply on the fundamental research and surgical treatment of brain tumors. As of late 2023, he has acted as the primary surgeon for over 7,000 clinical procedures. His surgical methodology prioritizes the preservation of neurological function, achieving a permanent functional impairment rate of 1.6% in motor and language areas during surgeries. Furthermore, his clinical interventions for highly malignant glioblastoma have contributed to an improved five-year survival rate of 15.5% within his patient cohort.

​

In parallel with his surgical practice, Dr. Jiang leads major initiatives in genomic research for neurosurgical oncology. He established the Chinese/Asian Glioma Genome Atlas (CGGA/AGGA) and has identified critical mechanisms responsible for the malignant progression and secondary epilepsy associated with gliomas. His discovery of specific fusion genes directly facilitated the development of a novel Class 1.1 targeted drug for brain tumors, advancing the clinical shift toward precision, molecular-pathology-based treatment for glioma patients.

Why Choose Dr. Tao Jiang?

Dr. Tao Jiang’s clinical practice is grounded in molecular pathology and precision medicine for neurosurgical oncology. For international patients facing complex glioma diagnoses, his approach emphasizes highly individualized treatment plans based on a tumor's specific genetic profile, moving beyond standardized protocols to target the biological drivers of the disease.

​

A primary focus of Dr. Jiang’s surgical methodology is the preservation of patient quality of life. By utilizing awake craniotomy techniques and established protocols for protecting motor and multilingual language areas, his surgical interventions aim to maximize tumor resection while mitigating risks to critical neurological functions.

​

Furthermore, as the Director of the Neurosurgery Center at Beijing Tiantan Hospital—a premier institution for neurological disorders—Dr. Jiang manages a high volume of complex intracranial tumors. This extensive clinical exposure, supported by a multi-dimensional omics database, ensures that patient assessments are informed by significant empirical data and ongoing clinical research.

Secure Clarity on Your Treatment Options Before Traveling

Navigating a complex neurological diagnosis requires objective, data-driven insights. Before committing to international travel, MedBridgeNZ facilitates secure, remote online consultations and second opinions with Dr. Tao Jiang and his team. By submitting your existing medical records, pathology reports, and imaging, you can receive a comprehensive pre-travel assessment directly from a leading specialist. This remote evaluation helps establish the viability of specific surgical or targeted therapies in China, allowing you to make an informed decision about your healthcare journey with confidence.

 

Disclaimer: MedBridgeNZ operates exclusively as a professional medical logistics and concierge firm. We do not provide clinical services, medical advice, diagnosis, or treatment. All medical assessments, treatment plans, and clinical decisions are generated solely by the attending medical professionals at the respective healthcare institutions.

Book an online consultation with Dr. Tao Jiang

Home > Specialists > Neurosurgery > Dr. Tao Jiang (江涛)

Areas of Expertise

  • Surgical treatment of neurosurgical diseases and glioma.

  • Personalized comprehensive treatment of glioma guided by molecular pathology.

  • Surgical and chemotherapy for intracranial tumors, including meningioma, schwannoma, primary intracranial lymphoma, germ cell tumors, brain metastases, and pituitary adenoma.

Verified Patient Satisfaction Metrics

⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating

  • 5.0/5.0 Clinical Outcome Satisfaction

  • 5.0/5.0 Bedside Manner & Professionalism

  • (Source: Statistics based on verified clinical outcomes and patient feedback logs from domestic medical registries.)

High Demand: Chosen by over 6,500 patients online for consultation and second opinions.

​

Work Experience

  • Director of the Neurosurgery Center, Beijing Tiantan Hospital.

  • Director of the Beijing Neurosurgical Institute.

  • Vice Dean of the Neurosurgery Faculty, Capital Medical University.

  • Deputy Director of the National Center for Neurological Disorders.

Social Affiliations

  • First Chairman of the Glioma Professional Committee of the Chinese Medical Doctor Association and the Chinese Anti-Cancer Association.

  • President of the Beijing Medical Science and Health Society.

  • Chairman of the Asian Glioma Genome Atlas Project.

  • Chinese Chairman of Global Glioma Clinical Trial Projects.

  • Group Leader in the Chinese Medical Association.

  • Chief Editor of "Nervous Diseases and Mental Health".

  • Deputy Chief Editor of "Journal of Clinical Surgery", "China Clinical Practical Medicine", and "Cancer Biology & Medicine".

Research Achievements

  • Established a multi-dimensional omics database for glioma.

  • Conducted molecular pathology research on glioma and introduced molecular subtyping into glioma classification prior to the WHO classification.

  • Identified the fusion gene PTPRZ1-MET and developed the targeted drug PLB-1001, with findings published in Cell.

  • Implemented awake craniotomy techniques and established a motor area protection technology system in China.

  • Developed a multilingual language area precise positioning and protection plan, and created a staged resection surgical approach for language-functional area glioma.

  • Published 362 papers in scientific journals such as Cell and PNAS as the corresponding author, with 10 cover articles, 15,700 citations, and an H-index of 66.

  • Led the formulation of multiple diagnosis and treatment guidelines and norms, including the "Glioma Diagnosis and Treatment Norms" and "Glioma Diagnosis and Treatment Guidelines" for the National Health Commission.

  • Holds one Class III medical device registration certificate and 25 domestic and international patents.

Awards & Honors

  • Top 10 Advances in Life Sciences in China (2018).

  • National Science and Technology Progress Award (Second Class, as first completer).

  • Provincial and Ministerial Award (First Class, three times).

  • 14th Guanghua Engineering Science and Technology Award.

  • Outstanding Communist Party Member of the Beijing Health System.

  • Beijing Advanced Worker.

  • Beijing Scholar (2019).

  • Member of the Academic Advisory Committee of the Chinese Academy of Medical Sciences.

  • Led the glioma precision diagnosis and treatment team to be awarded the Beijing Worker Pioneer title (2022).

Academic Profiles & Credentials

Verify Dr. Jiang's academic identity, research contributions, and peer-reviewed publications through the official international registries below:

  • PubMed Scholar Profile: Verify Dr. Tao Jiang's comprehensive clinical research and peer-reviewed publications via the National Library of Medicine database.

Selected Peer-Reviewed Publications

Below is a selection of Dr. Jiang's highly cited clinical research, demonstrating ongoing leadership in the treatment and diagnostic evaluation of complex conditions:

  • Wu, L., et al. (2022). Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma. Cancer discovery. 👉 Read on PubMed (PMID: 36122307)

  • Fang, S., et al. (2021). Tumor location-based classification of surgery-related language impairments in patients with glioma. Journal of Neuro-Oncology. 👉 Read on PubMed (PMID: 34599481)

  • Fang, S., et al. (2020). Awake craniotomy for gliomas involving motor-related areas: classification and function recovery. Journal of Neuro-Oncology. 👉 Read on PubMed (PMID: 32350781)

*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.

Frequently Asked Questions (FAQs)

How can I get a medical opinion from Dr. Jiang if I am not in China?

You do not need to travel to Beijing for an initial evaluation. MedBridgeNZ coordinates comprehensive remote second opinions and pre-travel assessments with Dr. Jiang’s department. Our team handles the secure transfer and necessary translation of your medical imaging and patient history to facilitate a thorough clinical review.

​

Is my specific type of brain tumor something Dr. Jiang treats?

Dr. Jiang specializes in the surgical and comprehensive treatment of gliomas, as well as a wide range of intracranial tumors including meningiomas and brain metastases. To confirm if his expertise aligns with your specific diagnosis, MedBridgeNZ can submit your current clinical data for an initial case review by his medical team.

​

If Dr. Jiang recommends surgery, what support does MedBridgeNZ provide?

Should the clinical assessment indicate that treatment at Beijing Tiantan Hospital is appropriate, MedBridgeNZ manages all logistical requirements for your medical journey. This includes facilitating hospital appointments, assisting with medical visa documentation, organizing accommodation, and providing professional bilingual accompaniment throughout your clinical visits.

 

How does Dr. Jiang's approach to glioma surgery differ?

His clinical framework heavily integrates molecular pathology to tailor treatments to the genetic makeup of the tumor. Additionally, his surgical techniques focus on advanced motor and language area protection during resection, aiming to optimize both the clinical outcome and the preservation of neurological function.

Flexible Ways to Connect with Your Expert

We understand that every patient’s situation is unique. Beyond the Remote Written Consultation, we offer a range of flexible ways to access elite medical expertise:

  • Remote Video Consultations: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.

  • On-Site Proxy Consultations: If you cannot travel, our dedicated team can visit the hospital in person on your behalf. We will present your medical records to the specialist, discuss your case, and provide you with a comprehensive report of the doctor’s findings.

  • In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.

How MedBridgeNZ Helps You:

MedBridgeNZ is your dedicated medical concierge. We do not provide medical advice but handle all logistics to ensure you receive care from experts like Dr. Tao Jiang. Our services include appointment booking, visa assistance, travel arrangements, and translation services for a stress-free medical trip to China.

bottom of page